Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Primary Hyperlipidemia or Mixed Dyslipidemia At Risk Of Cardiovascular Events

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2014
This study is a multicenter, double-blind, randomized study to access the efficacy, safety and tolerability of Bococizumab (PF-04950615; RN316) in subjects with hyperlipidemia receiving background statin therapy.
Epistemonikos ID: 741ad0dd86d8b34021b51d4502fb783ab8be0c63
First added on: May 11, 2024